返回
Simcere Pharmaceutical Group Limited（02096.HK）價格
02096.HK 股價走勢圖
SIMCERE PHARMA (02096.HK)
Simcere Pharmaceutical Group Limited
HK$0
0%
$0
休市： Jan 29, 16:00:00 HKT
暫無資料Earnings FAQ
02096.HK 最近的每股盈餘與預期相比如何？
Simcere Pharmaceutical Group Limited 02096.HK 上一季度的收入表現如何？
Simcere Pharmaceutical Group Limited 的收入預期是多少？
Simcere Pharmaceutical Group Limited 的盈利品質評分是多少？
Simcere Pharmaceutical Group Limited 何時發布財報？
Simcere Pharmaceutical Group Limited 的預期收益是多少？
Simcere Pharmaceutical Group Limited 是否超出收益預期？
關鍵數據
前收市價
--
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
8.2M
每股盈餘 (TTM)
0.40
股息收益率
--
市值
--
什麼是 SIMCERE PHARMA？
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.